J
Jaume Reventós
Researcher at International University Of Catalonia
Publications - 114
Citations - 7992
Jaume Reventós is an academic researcher from International University Of Catalonia. The author has contributed to research in topics: Endometrial cancer & Cancer. The author has an hindex of 39, co-authored 111 publications receiving 6408 citations. Previous affiliations of Jaume Reventós include Autonomous University of Barcelona & University of Lleida.
Papers
More filters
Journal ArticleDOI
New perspectives on screening and early detection of endometrial cancer
Laura Costas,Jon Frias-Gomez,Magdalena Guardiola,Yolanda Benavente,Marta Pineda,Miquel Angel Pavon,José Manuel Martinez,Maite Climent,Marc Barahona,Júlia Canet,Sonia Paytubi,Mónica Salinas,Luis Palomero,Ilaria Bianchi,Jaume Reventós,Gabriel Capellá,Mireia Diaz,August Vidal,Josep M. Piulats,Alvaro Aytes,Jordi Ponce,Joan Brunet,Francesc Bosch,Xavier Matias-Guiu,Laia Alemany,Silvia de Sanjosé,Screenwide Team +26 more
TL;DR: New perspectives on detection of endometrial cancer using genomic and other biomarkers in minimally invasive sampling methods are discussed with a special focus on public health classic screening criteria, highlighting current gaps in knowledge.
Journal ArticleDOI
A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.
Marina Rigau,Israel Ortega,Maria Carmen Mir,Carlos Ballesteros,Marta Garcia,Marta Llauradó,Eva Colas,Nuria Pedrola,Melania Montes,Tamara Sequeiros,Tugce Ertekin,Blanca Majem,Jacques Planas,Anna Ruiz,Miguel Abal,Alex Sánchez,Juan Morote,Juan Morote,Jaume Reventós,Andreas Doll +19 more
TL;DR: Monitoring an RNA transcript in post‐prostate massage urine for increasing the specificity of prostate‐specific antigen (PSA) in the detection of prostate cancer (PCa) may not necessarily reflect the multifactorial nature of PCa.
Journal ArticleDOI
Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion
Nuria Pedrola,Laura Devis,Marta Llauradó,Irene Campoy,Elena Martinez-Garcia,Marta Garcia,Laura Muinelo-Romay,Lorena Alonso-Alconada,Miguel Abal,Francesc Alameda,Gemma Mancebo,Ramon Carreras,Josep Castellví,Silvia Cabrera,Antonio Gil-Moreno,Xavier Matias-Guiu,Juan L. Iovanna,Eva Colas,Jaume Reventós,Jaume Reventós,Anna Ruiz +20 more
TL;DR: NID1 and NUPR1 are novel targets of ETV5 and are actively cooperating with ETV 5 at the invasion front of the tumor in the acquisition of an invasive phenotype to jointly drive endometrial cancer invasion.
Journal ArticleDOI
Targeted proteomics identifies proteomic signatures in liquid-biopsies of the endometrium to diagnose endometrial cancer and assist in the prediction of the optimal surgical treatment
Elena Martinez-Garcia,Antoine Lesur,Laura Devis,Silvia Cabrera,Xavier Matias-Guiu,Marc Hirschfeld,Marc Hirschfeld,Jasmin Asberger,Jan van Oostrum,María de los Ángeles Casares de Cal,Antonio Gómez-Tato,Jaume Reventós,Jaume Reventós,Bruno Domon,Eva Colas,Antonio Gil-Moreno,Antonio Gil-Moreno +16 more
TL;DR: Two uterine aspirate-based signatures to diagnose EC and classify tumors in the most prevalent histologic subtypes are developed to improve diagnosis and assist in the prediction of the optimal surgical treatment.
Journal ArticleDOI
Up‐regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma
Jesús Planagumà,Miguel Abal,Antonio Gil-Moreno,María Díaz-Fuertes,Marta Monge,Angel Garcia,Teresa Baró,Jordi Xercavins,Jaume Reventós,Francesc Alameda +9 more
TL;DR: RT‐Q‐PCR validated ERM/ETV5 up‐regulation in EEC and demonstrated a specific and significant increase restricted to those tumour stages associated with myometrial invasion, which lead to the proposal of a co‐operative role between ERM or ETV5 and RUNX1/AML1 during the early events of endometrial tumourigenesis.